| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Puma Biotechnology, Inc. (PBYI) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. PBYI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 227.5K | $1.83M | - | |
| Other | 70.3K | $565.4K | - | |
| CFO | 66.5K | $535.0K | - | |
| Dir | 54.0K | $434.2K | - | |
| Dir | 41.9K | $336.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2019 | Lo Steven | Chief Commercial Officer | Sell | 1,852 | $10.04 | $18,599.64 | -8.7% | |
| Jul 22, 2019 | Bryce Richard Paul | See Remarks | Sell | 1,841 | $10.10 | $18,588.76 | -4.8% | |
| Jul 22, 2019 | Auerbach Alan H62 | President And CEO | Sell | 12,715 | $9.98 | $126,846.11 | -0.3% | |
| Jul 2, 2019 | Auerbach Alan H62 | President And CEO | Sell | 495 | $12.78 | $6,326.10 | - | |
| Jul 2, 2019 | Bryce Richard Paul | See Remarks | Sell | 89 | $12.78 | $1,137.42 | -0.2% | |
| Jun 3, 2019 | Bryce Richard Paul | See Remarks | Sell | 88 | $15.07 | $1,326.16 | -0.2% | |
| Jun 3, 2019 | Auerbach Alan H62 | President And CEO | Sell | 483 | $15.18 | $7,331.94 | - | |
| May 2, 2019 | Bryce Richard Paul | See Remarks | Sell | 85 | $32.38 | $2,752.31 | -0.2% | |
| May 2, 2019 | Auerbach Alan H62 | President And CEO | Sell | 477 | $32.38 | $15,445.31 | - | |
| Apr 2, 2019 | Bryce Richard Paul | See Remarks | Sell | 88 | $35.78 | $3,148.65 | -0.2% |